NOVAJoint Research Project
Building a living knee replacement
ARPA-H Awards Columbia Researchers Nearly $39M to Develop a Living Knee Replacement
Columbia biomedical engineers are collaborating with orthopedic surgeons to build a living replacement knee to be tested in clinical trials within five years.
Credit: ARPA-H
A team of researchers from Columbia University Irving Medical Center (CUIMC) and Columbia Engineering has been awarded up to a $38.95 million contract from the Advanced Research Projects Agency for Health (ARPA-H) on Novel Innovations for Tissue Regeneration in Osteoarthritis (NITRO) to build a living knee replacement from biomaterials and human stem cells, including a patient’s own cells. ARPA-H is a federal funding agency that funds transformative biomedical and health research breakthroughs, rapidly translating research from the lab to applications in the marketplace. The NOVAJoint research team is developing a regenerative knee implant to restore full joint function to patients severely impacted by osteoarthritis (OA).
Learn more about our team, research updates, health equity goals, commercialization plans, and community engagement through the provided links.
Contact Us: novajoint@cumc.columbia.edu